Transcription factor heterogeneity and epiblast pluripotency

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1575, 2011, Pages 2230-2237

  Osorno, Rodrigo ^a   Chambers, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Heterogeneity; Pluripotency; Self renewal; Stem cell; Transcription factor

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

CYTOLOGY; GENE EXPRESSION; HETEROGENEITY; MOLECULAR ANALYSIS; PROBABILITY;

ANIMAL; ARTICLE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL;

ANIMALS; GENE EXPRESSION REGULATION; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS;

EID: 79960058253     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0043     Document Type: Article

References (78)

1. Solter, D. 2006 From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stemcell research. Nat. Rev. Genet. 7, 319-327. (doi:10.1038/nrg1827)
2. Chambers, I. & Smith, A. 2004 Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23, 7150-7160. (doi:10.1038/sj.onc.1207930)
3. Finch, B. W. & Ephrussi, B. 1967 Retention of multiple developmental potentialities by cells of a mouse testicular teratocarcinoma during prolongued culture in vitro and their extinction upon hybridization with cells of permanent lines. Proc. Natl Acad. Sci. USA 57, 615-621. (doi:10.1073/pnas.57.3.615)
4. Martin, G. R. & Evans, M. J. 1975 Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl Acad. Sci. USA 72, 1441-1445. (doi:10.1073/pnas.72.4.1441)
5. Martin, G. R. 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638. (doi:10.1073/pnas.78.12.7634)
6. Evans, M. J. & Kaufman, M. H. 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. (doi:10.1038/292154a0)
7. Gardner, R. L., Papaioannou, V. E. & Barton, S. C. 1973 Origin of the ectoplacental cone and secondary giant cells in mouse blastocysts reconstituted from isolated trophoblast and inner cell mass. J. Embryol. Exp. Morphol.30, 561-572.
8. Papaioannou, V. E. 1982 Lineage analysis of inner cell mass and trophectoderm using microsurgically reconstituted mouse blastocysts. J. Embryol. Exp. Morphol. 68, 199-209.
9. Hogan, B. 1994 Manipulating the mouse embryo: a laboratory manual, 2nd edn. Plainview, NY: Cold Spring Harbor Laboratory.
10. Bradley, A., Evans, M., Kaufman, M. H. & Robertson, E. 1984 Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256. (doi:10.1038/309255a0)
11. Brons, I. G. et al. 2007 Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195. (doi:10.1038/nature05950)
12. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L. & McKay, R. D. G. 2007 New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199. (doi:10.1038/ nature05972)
13. Hayashi, K. & Surani, M. A. 2009 Self-renewing epiblast stem cells exhibit continual delineation of germ cells with epigenetic reprogramming in vitro. Development 136, 3549-3556. (doi:10.1242/dev.037747)
14. Chambers, I. & Tomlinson, S. R. 2009 The transcriptional foundation of pluripotency. Development 136, 2311-2322. (doi:10.1242/dev.024398)
15. Williams Jr, D. C., Cai, M. & Clore, G. M. 2004 Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 279, 1449-1457. (doi:10.1074/jbc.M309790200)
16. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H. & Smith, A. 1998 Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391. (doi:10.1016/ S0092-8674(00)81769-9)
17. Chew, J. L. et al. 2005 Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 25, 6031-6046. (doi:10.1128/MCB.25.14.6031-6046.2005)
18. Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M. K., Vriend, G. & Scholer, H. R. 1998 New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12, 2073-2090. (doi:10.1101/ gad.12.13.2073)
19. Dailey, L., Yuan, H. & Basilico, C. 1994 Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell Biol.14, 7758-7769.
20. Nishimoto, M., Fukushima, A., Okuda, A. & Muramatsu, M. 1999 The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell Biol. 19, 5453-5465.
21. Tokuzawa, Y., Kaiho, E., Maruyama, M., Takahashi, K., Mitsui, K., Maeda, M., Niwa, H. & Yamanaka, S. 2003 Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell Biol. 23, 2699-2708. (doi:10.1128/ MCB.23.8.2699-2708.2003)
22. van den Berg, D. L., Zhang, W., Yates, A., Engelen, E., Takacs, K., Bezstarosti, K., Demmers, J., Chambers, I. & Poot, R. A. 2008 Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol. Cell Biol. 28, 5986-5995. (doi:10.1128/MCB.00301-08)
23. Ben-Shushan, E., Thompson, J. R., Gudas, L. J. & Bergman, Y. 1998 Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell Biol.18, 1866-1878.
24. Zhang, X., Zhang, J., Wang, T., Esteban, M. A. & Pei, D. 2008 Esrrb activates Oct4 transcription and sustains selfrenewal and pluripotency in embryonic stem cells. J. Biol. Chem. 283, 35825-35833. (doi:10.1074/jbc. M803481200)
25. Nakatake, Y. et al. 2006 Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol. Cell Biol. 26, 7772-7782. (doi:10.1128/MCB.00468-06)
26. Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R. & Rossant, J. 2005 Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123, 917-929. (doi:10.1016/j.cell.2005.08.040)
27. Catena, R. et al. 2004 Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J. Biol. Chem. 279, 41846-41857. (doi:10.1074/jbc. M405514200)
28. Boyer, L. A. et al. 2005 Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956. (doi:10.1016/j.cell.2005.08.020)
29. Loh, Y. H. et al. 2006 The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440. (doi:10.1038/ng1760)
30. Chen, X. et al. 2008 Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117. (doi:10. 1016/j.cell.2008.04.043)
31. Niwa, H., Miyazaki, J. & Smith, A. G. 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376. (doi:10.1038/74199)
32. Ambrosetti, D. C., Scholer, H. R., Dailey, L. & Basilico, C. 2000 Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 275, 23387-23397. (doi:10.1074/jbc.M000932200)
33. Ambrosetti, D. C., Basilico, C. & Dailey, L. 1997 Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17, 6321-6329.
34. Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S. Y., Suemori, H., Nakatsuji, N. & Tada, T. 2005 Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell Biol. 25, 2475-2485. (doi:10.1128/MCB.25.6.2475-2485.2005)
35. Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N. & Lovell-Badge, R. 2003 Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140. (doi:10.1101/gad. 224503)
36. Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., Lun, Y. & Lemischka, I. R. 2006 Dissecting self-renewal in stem cells with RNA interference. Nature 442, 533-538. (doi:10.1038/nature04915)
37. Masui, S. et al. 2007 Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635. (doi:10.1038/ ncb1589)
38. Jauch, R., Ng, C. K., Saikatendu, K. S., Stevens, R. C. & Kolatkar, P. R. 2008 Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. J. Mol. Biol. 376, 758-770. (doi:10.1016/j.jmb. 2007.11.091)
39. Chaney, B. A., Clark-Baldwin, K., Dave, V., Ma, J. & Rance, M. 2005 Solution structure of the K50 class homeodomain PITX2 bound to DNA and implications for mutations that cause Rieger syndrome. Biochemistry 44, 7497-7511. (doi:10.1021/bi0473253)
40. Mullin, N. & Chambers, I. 2011 The function of Nanog in pluripotency. In Nuclear reprogramming and stem cells (eds J. Ainscough, S. Yamanaka & T. Tada). Totowa, NJ: Humana Press.
41. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M. & Yamanaka, S. 2003 The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642. (doi:10.1016/ S0092-8674(03)00393-3)
42. Silva, J. et al. 2009 Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737. (doi:10.1016/j.cell. 2009.07.039)
43. Navarro, P., Chambers, I., Karwacki-Neisius, V., Chureau, C., Morey, C., Rougeulle, C. & Avner, P. 2008 Molecular coupling of Xist regulation and pluripotency. Science 321, 1693-1695. (doi:10.1126/science.1160952)
44. Messerschmidt, D. M. & Kemler, R. 2010 Nanog is required for primitive endoderm formation through a noncell autonomous mechanism. Dev. Biol. 344, 129-137. (doi:10.1016/j.ydbio.2010.04.020)
45. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. & Smith, A. 2003 Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655. (doi:10.1016/S0092-8674(03)00392-1)
46. Hart, A. H., Hartley, L., Ibrahim, M. & Robb, L. 2004 Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev. Dyn. 230, 187-198. (doi:10.1002/dvdy.20034)
47. O'Looney, B. 1859 Tir na n'Og. The Land of Youth (translation edited from 'Laoi Oisin i dTir na nOg' [The lay of Oisin in the land of youth], M. Comyn, 1750). Trans. Ossianic Soc. 4, 227-280.
48. Chambers, I. et al. 2007 Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234. (doi:10.1038/nature06403)
49. Takahashi, K. & Yamanaka, S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi:10.1016/j.cell.2006.07.024)
50. Hall, J. et al. 2009 Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell selfrenewal. Cell Stem Cell. 5, 597-609. (doi:10.1016/j. stem.2009.11.003)
51. Niwa, H., Ogawa, K., Shimosato, D. & Adachi, K. 2009 A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460, 118-122. (doi:10.1038/nature08113)
52. Ying, Q. L., Nichols, J., Chambers, I. & Smith, A. 2003 BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292. (doi:10.1016/ S0092-8674(03)00847-X)
53. Guo, G., Yang, J., Nichols, J., Hall, J. S., Eyres, I., Mansfield, W. & Smith, A. 2009 Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063-1069. (doi:10.1242/dev.030957)
54. Yeom, Y. I., Fuhrmann, G., Ovitt, C. E., Brehm, A., Ohbo, K., Gross, M., Hübner, K. & Schöler, H. R. 1996 Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122, 881-894.
55. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P. & Smith, A. 2008The ground state of embryonic stem cell self-renewal. Nature 453, 519-523.(doi:10.1038/nature06968)
56. Furusawa, T., Ohkoshi, K., Honda, C., Takahashi, S. & Tokunaga, T. 2004 Embryonic stem cells expressing both platelet endothelial cell adhesion molecule-1 and stagespecific embryonic antigen-1 differentiate predominantly into epiblast cells in a chimeric embryo. Biol. Reprod. 70, 1452-1457. (doi:10.1095/biolreprod.103.024190)
57. Furusawa, T., Ikeda, M., Inoue, F., Ohkoshi, K., Hamano, T. & Tokunaga, T. 2006 Gene expression profiling of mouse embryonic stem cell subpopulations. Biol. Reprod. 75, 555-561. (doi:10.1095/biolreprod.105. 049502)
58. Payer, B., Chuva de Sousa Lopes, S. M., Barton, S. C., Lee, C., Saitou, M. & Surani, M. A. 2006 Generation of stella-GFP transgenic mice: a novel tool to study germ cell development. Genesis 44, 75-83. (doi:10.1002/ gene.20187)
59. Hayashi, K., Lopes, S. M., Tang, F. & Surani, M. A. 2008 Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3, 391-401. (doi:10.1016/j. stem.2008.07.027)
60. Toyooka, Y., Shimosato, D., Murakami, K., Takahashi, K. & Niwa, H. 2008 Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135, 909-918. (doi:10.1242/dev.017400)
61. Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M, Heyworth, C. & Enver, T. 1997Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11, 774-785.(doi:10.1101/gad.11.6.774)
62. Suzuki, A., Raya, A., Kawakami, Y., Morita, M., Matsui, T., Nakashima, K., Gage, F. H., Rodríguez-Esteban, C. & Belmonte, J. C. I. 2006 Maintenance of embryonic stem cell pluripotency byNanog-mediated reversal ofmesoderm specification. Nat.Clin. Pract.Cardiovasc.Med. 3(Suppl. 1), S114-S122.(doi:10.1038/ncpcardio0442)
63. Niakan, K. K. et al. 2010 Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal. Genes Dev. 24, 312-326. (doi:10.1101/gad.1833510)
64. Canham, M. A., Sharov, A. A., Ko, M. S. & Brickman, J. M. 2010 Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript. PLoS Biol. 8, e1000379. (doi:10.1371/journal.pbio.1000379)
65. Guo, G., Huss, M., Tong, G. Q., Wang, C., Li Sun, L., Clarke, N. D. & Robson, P. 2010 Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell. 18, 675-685. (doi:10.1016/j.devcel.2010.02.012)
66. Yuan, H., Corbi, N., Basilico, C. & Dailey, L. 1995 Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9, 2635-2645. (doi:10.1101/gad.9.21.2635)
67. Nichols, J., Silva, J., Roode, M. & Smith, A. 2009 Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136, 3215-3222. (doi:10.1242/dev.038893)
68. Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J., Meloche, S. & Smith, A. 2007 FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134, 2895-2902. (doi:10.1242/dev.02880)
69. Stavridis, M. P., Lunn, J. S., Collins, B. J. & Storey, K. G. 2007 A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134, 2889-2894. (doi:10.1242/dev.02858)
70. Huang, S. 2011 Systems biology of stem cells: three useful perspectives to help overcome the paradigm of linear pathways. Phil. Trans. R. Soc. B 366, 2247-2259. (doi:10.1098/rstb.2011.0008)
71. Wood, H. B. & Episkopou, V. 1999 Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech. Dev. 86, 197-201. (doi:10.1016/S0925-4773(99)00116-1)
72. Damjanov, I., Solter, D., Belicza, M. & Skreb, N. 1971 Teratomas obtained through extrauterine growth of seven-day mouse embryos. J. Natl Cancer Inst. 46, 471-475.
73. Guo, G. & Smith, A. 2010 A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 137, 3185-3192. (doi:10.1242/dev.052753)
74. Yang, J., van Oosten, A. L., Theunissen, T. W., Guo, G., Silva, J. C. & Smith, A. 2010 Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319-328. (doi:10.1016/j.stem.2010.06.022)
75. Heng, J. C. et al. 2010 The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6, 167-174. (doi:10.1016/j.stem.2009.12.009)
76. Gu, P. et al. 2005 Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell Biol. 25, 3492-3505. (doi:10.1128/MCB.25.9.3492-3505.2005)
77. Han, D. W. et al. 2010 Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143, 617-627. (doi:10.1016/j.cell.2010.10.015)
78. Vallier, L. et al. 2009 Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136, 1339-1349. (doi:10.1242/dev.033951)